NGM BIOPHARMACEUTICALS INC - COM (NGM)

CUSIP: 62921N105

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / COM
Total 13F shares
41,122,220
Share change
-6,297,411
Total reported value
$35,321,273
Put/Call ratio
300%
Price per share
$0.86
Number of holders
79
Value change
-$5,621,280
Number of buys
33
Number of sells
51

Quarterly Holders Quick Answers

What is CUSIP 62921N105?
CUSIP 62921N105 identifies NGM - NGM BIOPHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NGM BIOPHARMACEUTICALS INC - COM (NGM) as of Q4 2023

As of 31 Dec 2023, NGM BIOPHARMACEUTICALS INC - COM (NGM) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,122,220 shares. The largest 10 holders included Column Group LLC, BlackRock Inc., VANGUARD GROUP INC, EcoR1 Capital, LLC, StepStone Group LP, ACADIAN ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, Euclidean Capital LLC, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP. This page lists 79 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.